These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8387371

  • 1. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor.
    Tsakona CP, Khwaja A, Goldstone AH.
    Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
    Gorin NC, Coiffier B, Hayat M, Philip T, Vernant JP, Hervé P, Colombat P, Boivin P, Slavin S, Eugène-Jolchine I.
    Bone Marrow Transplant; 1991 Apr; 7 Suppl 2():82. PubMed ID: 1878733
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
    Rosenfeld CS, Nemunaitis J.
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):19-26. PubMed ID: 1362822
    [No Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application.
    Neumanaitis J.
    Transfusion; 1993 Jan; 33(1):70-83. PubMed ID: 8424270
    [No Abstract] [Full Text] [Related]

  • 12. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution.
    Calderwood S, Doyle JJ, Hitzler JK, Saunders EF, Freedman MH.
    Bone Marrow Transplant; 1996 Jul; 18(1):87-91. PubMed ID: 8832000
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R, Borota J, Belić A, Gebauer E, Stefanović N.
    Med Pregl; 1997 Jul; 50(3-4):87-93. PubMed ID: 9229690
    [Abstract] [Full Text] [Related]

  • 15. The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.
    Rabinowe SN, Nemunaitis J, Armitage J, Nadler LM.
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):6-16. PubMed ID: 1712125
    [No Abstract] [Full Text] [Related]

  • 16. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
    Greenberg P, Advani R, Keating A, Gulati SC, Nimer S, Champlin R, Karanes C, Gorin NC, Powles RL, Smith A, Lamborn K, Cuffie C.
    Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma.
    Fay JW, Bernstein SH.
    Semin Oncol; 1996 Apr; 23(2 Suppl 4):22-7. PubMed ID: 8600545
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 19. Marketing of recombinant granulocyte-macrophage colony-stimulating factor approved by FDA.
    Clin Pharm; 1991 Jun; 10(6):411. PubMed ID: 2065520
    [No Abstract] [Full Text] [Related]

  • 20. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO.
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.